Fiduciary Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.97M Sell
7,562
-406
-5% -$213K 0.05% 197
2025
Q1
$5.05M Sell
7,968
-238
-3% -$151K 0.07% 168
2024
Q4
$5.85M Sell
8,206
-316
-4% -$225K 0.08% 150
2024
Q3
$8.96M Buy
8,522
+26
+0.3% +$27.3K 0.13% 112
2024
Q2
$8.93M Buy
8,496
+58
+0.7% +$61K 0.13% 107
2024
Q1
$8.12M Hold
8,438
0.12% 118
2023
Q4
$7.41M Buy
8,438
+1
+0% +$878 0.12% 115
2023
Q3
$6.94M Sell
8,437
-43
-0.5% -$35.4K 0.13% 111
2023
Q2
$6.09M Sell
8,480
-29
-0.3% -$20.8K 0.11% 131
2023
Q1
$6.99M Sell
8,509
-152
-2% -$125K 0.13% 123
2022
Q4
$6.25M Sell
8,661
-370
-4% -$267K 0.12% 132
2022
Q3
$6.22M Sell
9,031
-6,859
-43% -$4.72M 0.13% 122
2022
Q2
$9.39M Buy
15,890
+5
+0% +$2.96K 0.2% 99
2022
Q1
$11.1M Sell
15,885
-126
-0.8% -$88K 0.2% 101
2021
Q4
$10.1M Sell
16,011
-15
-0.1% -$9.47K 0.17% 110
2021
Q3
$9.7M Buy
16,026
+367
+2% +$222K 0.17% 108
2021
Q2
$8.75M Buy
15,659
+297
+2% +$166K 0.17% 118
2021
Q1
$7.27M Buy
15,362
+79
+0.5% +$37.4K 0.15% 131
2020
Q4
$7.38M Buy
15,283
+1,918
+14% +$927K 0.15% 123
2020
Q3
$7.48M Sell
13,365
-958
-7% -$536K 0.18% 104
2020
Q2
$8.93M Buy
14,323
+527
+4% +$329K 0.22% 89
2020
Q1
$6.74M Buy
13,796
+9
+0.1% +$4.39K 0.2% 99
2019
Q4
$5.18M Buy
13,787
+4,721
+52% +$1.77M 0.12% 134
2019
Q3
$2.52M Buy
9,066
+1,962
+28% +$544K 0.06% 184
2019
Q2
$2.22M Buy
7,104
+1,635
+30% +$512K 0.06% 187
2019
Q1
$2.25M Buy
+5,469
New +$2.25M 0.06% 183